<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Some <z:mp ids='MP_0001845'>inflammation</z:mp> factors have been shown to accelerate type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> macrovascular complication (T2DMC) </plain></SENT>
<SENT sid="1" pm="."><plain>The study investigates the variation of TNF-α and IL-6 levels during the progression of T2DMC to explore their predictive value in the incidence of T2DMC </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> participants were divided into two groups, type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) and non-<z:mp ids='MP_0002055'>diabetes</z:mp> (ND) group </plain></SENT>
<SENT sid="3" pm="."><plain>TNF-α and IL-6 were analyzed with enzyme immunoassay </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> participants were followed up by carotid Doppler, Doppler of lower extremities, head CT and 64-row multislice spiral CTA </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of macrovascular <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in T2DM was significantly higher than that in ND group (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>The levels of TNF-α and IL-6 in both groups with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> increased annually </plain></SENT>
<SENT sid="7" pm="."><plain>In patients who had <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> with <z:mp ids='MP_0002055'>diabetes</z:mp>, measured levels of TNF-α and IL-6 were significantly higher than those in patients with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> without <z:mp ids='MP_0002055'>diabetes</z:mp> (P &lt; 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The levels of TNF-α and IL-6 in T2DMC and ND group with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> was significantly higher than that in two groups without <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with T2DM were divided into four groups according to their HbA1C level </plain></SENT>
<SENT sid="10" pm="."><plain>There was a strong positive correlation between the levels of TNF-α and IL-6 and HbA1C (P &gt; 0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>The TNF-α and IL-6 levels can be used as predictors for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> development </plain></SENT>
<SENT sid="12" pm="."><plain>Compared with non-diabetic <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, TNF-α and IL-6 have stronger predictive value in diabetic <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> development </plain></SENT>
<SENT sid="13" pm="."><plain>One reason for <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> increasing <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> is to activate inflammatory cells and relives of inflammatory factors </plain></SENT>
<SENT sid="14" pm="."><plain><z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> can trigger <z:mp ids='MP_0001845'>inflammation</z:mp>, which is a quality-effect relationship reaction </plain></SENT>
</text></document>